CD19 and lymphoblastic lymphoma: Li et al. [28] performed a study at the Children’s Hospital of Philadelphia to investigate the efficacy of combining PD-1 inhibitors with anti-CD19 CART Therapy in paediatric patients with R/R multi-line B-ALL and lymphoblastic lymphoma.